Arcadio, Arvie B.

HRN: 28-13-59  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2025
CEFTRIAXONE 1G (VIAL)
11/24/2025
12/01/2025
IV
2g
Daily
Transected Muscle
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines